Wednesday, November 7, 2012

• Top Buys by Top Brass: Chief Executive Officer Hecht's $582.5K Bet on IRWDat Forbes (Wed, Nov 7)
• 5 Stocks With Big Insider Buyingat TheStreet (Wed, Nov 7)

Tuesday, November 6, 2012

• IRONWOOD PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online (Tue, Nov 6)

Thursday, November 1, 2012

• A Capital-Efficient Prescription For New Drugs: Raghuram "Ram" Selvarajuat Seeking Alpha (Thu, Nov 1)
• Ironwood Pharmaceuticals re-ups, expands in Cambridgeat bizjournals.com (Thu, Nov 1)

Wednesday, October 31, 2012

• IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct FinEDGAR Online (Wed, Oct 31)

Monday, October 29, 2012

• The Zacks Analyst Blog Highlights: Agilent Technologies, STMicroelectronics, Forest Laboratories, Ironwood Pharmaceuticals and ITT Educational ServicesZacks (Mon, Oct 29)
• IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements andEDGAR Online (Mon, Oct 29)

Sunday, October 28, 2012

• China Biotech In Review: U.S. Medical Device Makers Turn Attention To 2nd And 3rd Tier Citiesat Seeking Alpha (Sun, Oct 28)

Friday, October 26, 2012

• Earnings Scorecard: Forest LabsZacks (Fri, Oct 26)

Thursday, October 25, 2012

• Ironwood Implies Upside For Synergy; Lessons Learned From Dendreonat Seeking Alpha (Thu, Oct 25)
• Synergy Pharmaceutical Could Almost Double In Value With Plecanatideat Seeking Alpha (Thu, Oct 25)

Wednesday, October 24, 2012

• Nike Analyst Deems 10%-15% Dividend Increase Plausible and 3 Must-See Stock Analysesat Wall St. Cheat Sheet (Wed, Oct 24)
• Synergy Pharma: Plecanatide Topline Data To Serve As Catalyst For Stockat Seeking Alpha (Wed, Oct 24)

Tuesday, October 23, 2012

• Amarin Gets Patents, AstraZeneca Works With Ironwood: Healthcare Business Updateat Wall St. Cheat Sheet (Tue, Oct 23)
• How Healthy are Healthcare Stocks?at Wall St. Cheat Sheet (Tue, Oct 23)
• Ironwood inks deal with AstraZeneca worth upwards of $150Mat bizjournals.com (Tue, Oct 23)
• Ironwood long-term outlook positive, says Ladenburgtheflyonthewall.com (Tue, Oct 23)
• AstraZeneca, Ironwood partner on IBS drug in ChinaAP (Tue, Oct 23)

Monday, October 22, 2012

• 3 Earnings Reports That Caught My Attention Last Weekat Motley Fool (Mon, Oct 22)

Thursday, October 18, 2012

• Ironwood Pharma Beats on All FrontsZacks (Thu, Oct 18)
• Ironwood Pharmaceuticals Inc. Stock Upgraded (IRWD)at TheStreet (Thu, Oct 18)

Tuesday, October 16, 2012

• Ironwood Pharmaceuticals' CEO Hosts the 3Q 2012 Investor Update Conference Call - (Transcript)at Seeking Alpha (Tue, Oct 16)
• Ironwood Pharma posts 3Q profit on drug approvalAP (Tue, Oct 16)
• IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementsEDGAR Online (Tue, Oct 16)

Add IRWD News to My Yahoo!